Walgreens Boots Alliance, Inc.
WBA
NASDAQ40.78
Walgreens Boots Alliance, Inc.
NASDAQ:WBA
RECENT
PRICE
40.78
P/E
RATIO
6.96
(PEG:0.10)
P/E RATIO
RELATIVE
TO S&P
0.35
DIV
YLD
4.62%
High:
Low:
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Legends
Stock price
0.71 Beta (1.0 Market)
0
0
0
0
0
0
0
0
0
% total return 11/22:
Stock
S&P
1y.
0
0
3y.
0
0
5y.
0
0
0
Percent shares traded:
0
0
0
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Fiscal year
46.93
1.73
1.09
0.26
53.84
2.04
0.57
0.31
59.59
2.18
0.82
0.38
63.97
2.03
2.21
0.45
68.68
2.13
2.78
0.55
78.88
2.97
2.66
0.71
81.89
2.43
3.29
0.90
76.34
2.59
3.27
1.10
80.15
2.03
2.92
1.26
99.16
4.05
4.23
1.33
108.35
3.85
6.02
1.44
110.12
3.80
5.50
1.61
132.73
5.07
6.96
1.75
148.53
4.32
4.22
1.78
158.67
0.52
4.67
1.99
153.23
2.94
4.83
1.87
153.52
5.02
2.50
1.92
Revenue per share
Earnings per share
Free Cash Flow per sh
Dividends per share
1.32
10.01
1.79
11.12
2.25
12.99
1.95
14.52
1.03
14.67
1.33
16.22
1.77
20.85
1.28
20.56
1.16
21.46
1.20
29.58
1.22
27.59
1.26
25.59
1.38
26.24
1.85
25.51
1.56
23.47
1.59
27.08
2.01
33.97
CAPEX per share
Book Value per share
1,010
999
991
990
982
915
875
946
953
1,043
1,083
1,074
991
922
879
865
864
Comm.Shares outs.(m)
25.5
1.41
0.59%
21.4
1.23
0.71%
15.1
0.70
1.16%
15.6
0.22
1.43%
15.7
0.76
1.65%
13.1
0.80
1.82%
14.0
0.94
2.64%
19.0
1.12
2.23%
32.7
1.80
1.90%
21.0
1.05
1.56%
21.0
0.95
1.78%
20.9
0.88
2.02%
13.9
0.56
2.50%
13.6
0.56
3.04%
82.5
2.18
4.64%
17.0
0.57
3.73%
8.3
0.41
4.62%
Avg. annual P/E ratio
P/E relative to S&P500
Avg. annual div. yield
Capital Structure (31/8/22 | Q4)
Total liabilities
$60,758 m.
Total assets
$90,124 m.
Long-term debt
$32,132 m.
Cash and equiv.
$1,358 m.
Goodwill $22,280 m.
Retained earnings $41,117 m.
Common stock 865 m. shares
Market Capitalisation
$35,527 m. (as of 30/11/22)
72,184
6.0%
71,633
4.8%
72,217
5.5%
76,392
5.5%
103,444
4.5%
117,351
5.1%
118,214
4.7%
131,537
4.9%
136,866
3.7%
139,537
0.9%
132,509
1.8%
132,703
1.0%
Revenue (m)
Operating margin
1,086
2,714
1,166
2,127
1,283
2,450
1,316
1,932
1,742
4,220
1,718
4,173
1,654
4,078
1,770
5,024
2,038
3,982
1,927
456
1,973
2,542
1,990
4,337
Depreciation (m)
Net profit (m)
36.8%
3.8%
37.0%
3.0%
37.1%
3.4%
42.9%
2.5%
19.9%
4.1%
19.4%
3.6%
15.7%
3.4%
16.7%
3.8%
13.0%
2.9%
48.5%
0.3%
33.4%
1.9%
0.7%
3.3%
Income tax rate
Net profit margin
4,239
2,396
14,847
2,038
4,073
18,236
2,991
4,477
19,454
3,347
3,736
20,457
3,100
13,315
30,861
8,870
18,705
29,880
1,206
12,684
27,466
(3,821)
12,431
26,007
(7,069)
11,098
23,512
(8,997)
12,203
20,637
(6,240)
29,828
23,419
(5,681)
32,132
29,366
Working capital (m)
Long-term debt (m)
Equity (m)
14.2%
15.9%
18.3%
8.8%
10.4%
11.7%
9.6%
11.4%
12.6%
7.3%
9.7%
9.4%
9.1%
8.6%
13.7%
8.4%
8.0%
14.0%
10.0%
8.5%
14.8%
12.1%
9.8%
19.3%
11.1%
7.9%
16.9%
1.3%
1.7%
2.2%
4.7%
5.1%
10.9%
7.0%
5.3%
14.8%
ROIC
Return on capital
Return on equity
Working Capital
2020
2021
2022
Cash assets
516
1,193
1,358
Receivables
7,132
5,663
5,017
Inventory
9,451
8,159
8,353
Other
974
799
1,060
Current assets
18,073
15,814
16,902
Acc. Payable
14,458
11,136
11,255
Debt due
5,965
3,565
3,345
Other
6,647
7,353
7,983
Current liab.
27,070
22,054
22,583
74.1%
84.1%
76.2%
110.1%
63.0%
68.7%
57.6%
53.6%
37.9%
68.3%
67.2%
59.1%
62.5%
41.6%
57.7%
117.7%
65.4%
101.0%
58.7%
149.1%
(283.1)%
81.2%
36.4%
41.4%
Plowback ratio
Div.&Repurch. to FCF
Walgreens Boots Alliance, Inc. (US) started trading on December 3, 2014 (cik: 0001618921), operates in the Healthcare sector (Pharmaceutical Retailers industry), has 200,000 full-time employees, and is led by Mr. Stefano Pessina. Walgreens Boots Alliance, Inc. operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides health and wellness, and specialty and home delivery pharmacy services. As of August 31, 2022, this segment operated 8,886 retail stores under the Walgreens and Duane Reade brands in the United States; and 3 specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2022, this segment operated 3,989 retail stores under the Boots, Benavides, and Ahumada brands in the United Kingdom, Thailand, the Republic of Ireland, and Chile; and 543 optical practices, including 160 on a franchise basis. The U.S. Healthcare segment provides value-based primary care services; post-acute and home care management services; and clinical healthcare services. It also operates as a specialty pharmacy integrator and accelerator for hospitals. As of August 31, 2022, this segment operated 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Annual rates
(avg rate of change)
Past
5 y.
Past
10 y.
Revenues
0.28%
7.53%
Cash flow
-21.13%
2.13%
Earnings
104.70%
59.54%
Dividends
-1.01%
5.64%
Book value
4.26%
6.28%
Insider trading
Type
Shares
Date
Ban Kevin M.
Exempt
10,303
11/18/22
Ban Kevin M.
Sale
10,303
11/18/22
Ban Kevin M.
Exempt
10,303
11/18/22
Schlichting Nancy M
Sale
16,570
11/17/22
May Holly
InKind
957
11/01/22
Fiscal Year Ends
Quarterly Revenue (m)
Full fiscal year
I
II
III
IV
2020
34,339
35,820
34,631
34,746
139,536
2021
36,307
32,779
34,030
34,262
137,378
2022
33,901
33,756
32,597
32,449
132,703
Fiscal Year Ends
Earnings per share
Full fiscal year
I
II
III
IV
2020
0.96
1.08
(1.94)
0.42
0.52
2021
(0.36)
1.19
1.38
0.73
2.94
2022
4.14
1.02
0.33
(1.03)
4.47
Fiscal Year Ends
Quarterly dividends paid
Full fiscal year
I
II
III
IV
2020
- -
0.51
0.46
0.55
- -
2021
0.47
0.47
0.47
0.47
1.87
2022
0.48
0.49
0.48
0.47
1.92
11/07/2022
Walgreens Unit Strikes Roughly $9 Billion Deal With Summit Health
The Wall Street Journal - Read more...
11/02/2022
CVS, Walgreens to Pay More Than $10 Billion to Settle Opioid Lawsuits
The Wall Street Journal - Read more...
09/20/2022
Walgreens to Take Full Ownership of Shields Health
The Wall Street Journal - Read more...
08/17/2022
CVS, Walgreens and Walmart Ordered to Pay $650 Million to Ohio Counties in Opioid Case
The Wall Street Journal - Read more...
08/11/2022
Walgreens Offers Bonuses Up to $75,000 to Recruit Pharmacists
The Wall Street Journal - Read more...
08/10/2022
Walgreens Helped Fuel San Francisco Opioid Epidemic, Judge Rules
The Wall Street Journal - Read more...
07/08/2022
Higher Financing Costs, Lower Valuations Crimp M&A
The Wall Street Journal - Read more...
06/30/2022
Walgreens Profit Shrinks After Opioid Deal, Fewer Vaccinations
The Wall Street Journal - Read more...
05/04/2022
Walgreens Names Heads of Marketing, Merchandising and Product
The Wall Street Journal - Read more...
04/27/2022
Walmart, CVS Block or Delay Telehealth Adderall Prescriptions
The Wall Street Journal - Read more...
03/31/2022
Walgreens Posts Higher Sales, Powered by Covid-19 Vaccine, Testing Demand
The Wall Street Journal - Read more...
01/14/2022
Walgreens, CVS Shut Some Pharmacies on Weekends as Omicron Strains Staffing
The Wall Street Journal - Read more...
01/06/2022
Walgreens Posts Higher Sales and Profit From Covid-19 Demand
The Wall Street Journal - Read more...
01/06/2022
Bitcoin, Bed Bath & Beyond, Walgreens, Exxon: What to Watch in the Stock Market Today
The Wall Street Journal - Read more...
11/24/2021
Walgreens, Walmart, CVS Contributed to Opioid Epidemic, Ohio Jury Finds
The Wall Street Journal - Read more...
10/14/2021
Walgreens to Invest $5.2 Billion in VillageMD
The Wall Street Journal - Read more...
10/14/2021
Morgan Stanley, Citigroup, Plug Power: What to Watch in the Stock Market Today
The Wall Street Journal - Read more...
10/14/2021
Retailers Vetted Theranos Without Testing Devices
The Wall Street Journal - Read more...
09/24/2021
Pharmacies Prepare for Broader Covid-19 Booster Distribution
The Wall Street Journal - Read more...
09/15/2021
Biden Meets With Executives on Vaccine Mandate
The Wall Street Journal - Read more...
07/01/2021
Walgreens Sales Rise as Vaccinations Improve Prescriptions Business
The Wall Street Journal - Read more...
07/01/2021
Krispy Kreme, Micron Technology, CureVac: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
03/31/2021
Walgreens Reports Stronger Profit as Covid-19 Vaccine Rollout Ramps Up
The Wall Street Journal - Read more...
03/31/2021
Chewy, Deliveroo and Credit Suisse: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
01/27/2021
Roz Brewer to Bring Pandemic Experience to Walgreens at Pivotal Time
The Wall Street Journal - Read more...
01/27/2021
GameStop, Microsoft, AMC: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
01/27/2021
Walgreens Poaches Starbucks Executive Rosalind Brewer for CEO
The Wall Street Journal - Read more...
01/22/2021
IBM, Intel, Adamis, GameStop: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
01/13/2021
KB Home, GM, Ally Financial: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
01/07/2021
Bed Bath & Beyond, Micron Technology, Moderna: What to Watch When the Market Opens
The Wall Street Journal - Read more...
01/06/2021
Walgreens Boots to Sell Pharmacy Wholesale Unit
The Wall Street Journal - Read more...
01/06/2021
Facebook, AmerisourceBergen, JPMorgan: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
12/11/2020
Los Angeles County Pulls Nursing Homes From Federal Covid-19 Vaccine Plan
The Wall Street Journal - Read more...
12/02/2020
CVS, Walgreens Gear Up to Deliver Covid-19 Vaccines to Nursing Homes
The Wall Street Journal - Read more...